Health Encyclopedia

Renal cell carcinoma

Definition

Renal cell carcinoma is a type of kidney cancer in which the cancerous cells are found in the lining of very small tubes (tubules) in the kidney.

Alternative Names

Renal cancer; Kidney cancer; Hypernephroma; Adenocarcinoma of renal cells; Cancer - kidney

Causes, incidence, and risk factors

Renal cell carcinoma is the most common type of kidney cancer in adults. It occurs most often in men ages 50-70.

The exact cause is unknown.

Risk factors include:

Dialysis treatment
Family history of the disease
Genetics
Smoking
Von Hippel-Lindau disease (a hereditary disease that affects the capillaries of the brain, eyes, and other body parts)

Symptoms

Abdominal pain
Abnormal urine color (dark, rusty, or brown)
Back pain
Blood in the urine
Emaciated, thin, malnourished appearance
Enlargement of the veins around a testicle (varicocele)
Flank pain
Swelling or enlargement of the abdomen
Unintentional weight loss of more than 5% of body weight

Other symptoms that can occur with this disease:

Sometimes both kidneys are involved. The cancer spreads easily, most often to the lungs and other organs. In about one-third of patients, the cancer has already spread (metastasized) at the time of diagnosis.

Signs and tests

Pressing with the fingers (palpation) on the abdomen may show a mass or organ enlargement, particularly of the kidney or liver. Men may have a varicocele in the scrotum (a varicocele that is only on the right side is especially suspicious.)

Tests include:

Abdominal CT scan
Complete blood count (CBC)
Intravenous pyelogram (IVP)
Liver function tests
Renal arteriography
Serum calcium
Ultrasound of the abdomen and kidney
Urine cytology
Urine test (urinalysis)

The following tests may be performed to see if the cancer has spread:

Treatment

Surgical removal of all or part of the kidney (nephrectomy) is recommended. This may include removing the bladder or surrounding tissues or lymph nodes.

Radiation therapy does not usually work for renal cell carcinoma so it is not often used. Hormone treatments may reduce the growth of the tumor in some cases.

Chemotherapy is generally not effective for treating renal cell carcinoma. The drug interleukin-2 (IL-2) is effective in a small percentage of patients, but it is very toxic. Other chemotherapy drugs have been used, but patients generally do not live long once the disease has spead outside the kidney.

Newer therapies include sorafenib (Nexavar), sunitinib (Sutent), and temsirolimus (Torisel). The biologic drug bevacizumab (Avastin) has also been used.

A cure is unlikely unless all of the cancer is removed with surgery.

Support Groups

You can ease the stress of illness by joining a support group whose members share common experiences and problems. See cancer - support group and kidney disease - support group.

Expectations (prognosis)

The outcome depends on how much the cancer has spread and how well it responds to treatment. The survival rate is highest if the tumor is in the early stages and has not spread outside the kidney. If it has spread to the lymph nodes or to other organs, the survival rate is much lower.

Complications

High blood pressure ( hypertension)
High calcium level
High red blood cell count
Liver function abnormalities
Spread of the cancer

Calling your health care provider

Call your health care provider any time you see blood in the urine. Also call if you have any other symptoms of this disorder.

Prevention

Stop smoking. Follow your health care provider's recommendations in the treatment of kidney disorders, especially those that may require dialysis.

References

Barjorin D. Tumors of the kidney, bladder, ureters, and renal pelvis. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007: chap 2007.

National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Kidney Cancer. National Comprehensive Cancer Network; 2009. Version 1.2009.

Review Date:2/12/2009
Reviewed By:David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.